European Medicines Agency - Regulatory - Regulation of medicines

5 -Training and educational capacity to build competencies



    Description

Name

 

ReSViNET - Respiratory Syncytial Virus Network

Evidence of collaboration with regulatory authorities Yes Regular contact with EMA. EMA, FDA, WHO participate regularly in our yearly meetings to discuss different issues regarding RSV research and trials.
Capacity to provide competent consultation to regulatory authorities Yes
Formal meetings for clinical trials Yes
Training courses given over the last 2 years No
Training courses received over the last 2 years No
Promotion of participation in clinical trials in countries with limited resources
List of Countries